<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Paternally expressed gene 10 (<z:chebi fb="0" ids="46550">PEG10</z:chebi>) is important for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> resistance in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells; however, the effect of <z:chebi fb="0" ids="46550">PEG10</z:chebi> on <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor cell migration</z:e> remains poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the effects of <z:chebi fb="0" ids="46550">PEG10</z:chebi> on proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and migration in the Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, Raji </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was induced by <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) in pcDNA3.0/<z:chebi fb="0" ids="46550">PEG10</z:chebi> transiently transfected HEK293T cells and <z:chebi fb="0" ids="46550">PEG10</z:chebi>-suppressed Raji cells </plain></SENT>
<SENT sid="3" pm="."><plain>siRNAPEG10 was used to inhibit <z:chebi fb="0" ids="46550">PEG10</z:chebi> expression </plain></SENT>
<SENT sid="4" pm="."><plain>Fluorescence-activated cell sorting (FACS) were performed to analyze the effect of <z:chebi fb="0" ids="46550">PEG10</z:chebi> on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>CCK-8 were performed to detect cell proliferation and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Matrigel invasion were performed using <z:chebi fb="0" ids="46550">PEG10</z:chebi>-suppressed Raji cells to investigate cell migration </plain></SENT>
<SENT sid="7" pm="."><plain>The expression levels of matrix metalloproteinases -2and -9 (MMP-2 and MMP-9) were analyzed in <z:chebi fb="0" ids="46550">PEG10</z:chebi>-suppressed Raji cells using both real-time RT-PCR and Western blot analysis </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: HEK293T cells that overexpressed <z:chebi fb="0" ids="46550">PEG10</z:chebi> exhibited greater viability 48 h following treatment with 5-FU, relative to control cells </plain></SENT>
<SENT sid="9" pm="."><plain>Specific inhibition of <z:chebi fb="0" ids="46550">PEG10</z:chebi> expression by siRNA resulted in inhibition of growth and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Raji cells </plain></SENT>
<SENT sid="10" pm="."><plain>Adherence and invasion capabilities were downregulated and expression levels of MMP-2 and MMP-9 were reduced in <z:chebi fb="0" ids="46550">PEG10</z:chebi>-suppressed Raji cells </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Our findings demonstrated that <z:chebi fb="0" ids="46550">PEG10</z:chebi> enhances the apoptotic resistance and viability of Raji cells </plain></SENT>
<SENT sid="12" pm="."><plain>The migration and adherence invasion capacity of Raji cells could potentially be affected by regulation of the expression of MMP-2 and MMP-9 </plain></SENT>
<SENT sid="13" pm="."><plain>Our research provides a promising strategy for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunotherapy of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>